SCHEMBL5490504

SCHEMBL5490504

C=Cc1ccccc1OCC(=O)CBr

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.49
ALDH1A1 P00352 5/20 0.41
HPGD P15428 4/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HTT P42858 1/20 0.41
USP2 O75604 1/20 0.40
MMP2 P08253 1/20 0.40
MMP3 P08254 1/20 0.40
MMP13 P45452 1/20 0.40
MMP14 P50281 1/20 0.40
MAPK1 P28482 2/20 0.40
TSHR P16473 1/20 0.40
HSD17B10 Q99714 1/20 0.40
KDM4E B2RXH2 2/20 0.38
GAA P10253 1/20 0.38
MAPT P10636 2/20 0.37
NPC1 O15118 2/20 0.37
S1PR4 O95977 1/20 0.37
LMNA P02545 1/20 0.37
ITGA4 P13612 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6687183 0.81 PTGDR2 (0.72) PTGDR2ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL16933892 0.81 ALDH1A1 (0.45) PTGDR2ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL10627483 0.80 PTGDR2 (0.51) PTGDR2ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL17863711 0.80 PTGDR2 (0.51) PTGDR2ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL1397119 0.77 USP2 (0.47) PTGDR2ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL10555350 0.76 PTGDR2 (0.47) PTGDR2ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL29128330 0.76 GRM4 (0.57) ALDH1A1HPGDSMN1; SMN2HTTUSP2
SCHEMBL17858528 0.75 ALDH1A1 (0.48) PTGDR2ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL8020802 0.75 PTGDR2 (0.45) PTGDR2ALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL10558918 0.74 PTGDR2 (0.45) PTGDR2ALDH1A1HPGDSMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109415643-A Lubriation material and SRT material 国立大学法人京都大学 2019-03-01 CN disclosed
CN-109415604-A Film for plastic repair, surface protective article, and method for producing film for plastic repair 捷恩智株式会社 2019-03-01 CN disclosed
CN-106794678-B Laminate, surface protection article, and method for producing laminate 捷恩智株式会社 2019-02-01 CN disclosed
CN-103153617-B Laminate and manufacture method thereof JNC CORP. (JP) 2015-11-25 CN disclosed
EP-1548020-B1 SILICON COMPOUND JNC CORP (JP) 2014-07-23 EP disclosed
CN-103153617-A Laminate body and manufacturing method thereof JNC CORP 2013-06-12 CN disclosed
US-7294732-B2 Cyclic polysilsequisiloxanes substituted with a group containing a sulfonyl halide, especially ahalosulfonylphenyl group; living radical polymerization initiators, particularly for preparing acrylic polymers CHISSO CORPORATION (JP) 2007-11-13 US disclosed
US-20050288468-A1 Cyclic polysilsequisiloxanes substituted with a group containing a sulfonyl halide, especially ahalosulfonylphenyl group; living radical polymerization initiators, particularly for preparing acrylic polymers JNC CORPORATION (JP) 2005-12-29 US disclosed
EP-1548020-A1 SILICON COMPOUND CHISSO CORPORATION (JP) 2005-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288468-A1 Cyclic polysilsequisiloxanes substituted with a group containing a sulfonyl halide, especially ahalosulfonylphenyl group; living radical polymerization initiators, particularly for preparing acrylic polymers STS, SULT1A1, SRM PTGDR2 2674/4885ALDH1A1 384/4885HPGD 2804/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.